SLC7A11 and hepatocellular carcinoma: Given that intracellular cysteine deficiency via inhibition of xCT activity mediates sorafenib-induced ferroptosis in HCC [10, 11], the existence of alternative pathways for acquisition of cysteine by HCC are potentially responsible for the limited antitumor effects of sorafenib.